Synta Pharmaceuticals Prices Public Offering of Common Stock

14-11-2013 Business Wire HealthComments (0)

PharmaceuticalSynta Pharmaceuticals

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that it has priced an underwritten public offering of 14,000,000 shares of its common stock at a price to the public of $3.75 per share. Gross proceeds to Synta are expected to be approximately $52.5 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Synta. The offering is expected to close on or about November 18, 2013, subject to satisfacti

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top